Wednesday, February 06, 2019 6:25:15 PM
I agree it’s all politics, but they put out bids the opportunity to work with LSU on providing medication and we won. After investing $9,000,000.00 they should allow us and our State University Partners From LSU to Complete our growth and medication extraction and distribution via licensed pharmacies to qualified patients with proper prescriptions.
I do not agree that we should put cash in a paper bag and deliver it.
We’re a public company already working in a grey area, r.e, Federal vs State Government.
Their big beef is they want any private testing company to have 5 years minimum experience.
Within our industry I don’t believe there is such a qualifying company.
Qwest qualifies but is not interested until the Federal Ban is lifted.
However, Evio Labs is already testing in a dozen locations in 5 states as can be seen below,
Not allowing them to test is punitive and I believe our best remedy is in the courts.
Not dropping off a bag full of cash.
It will continuee to take time and will cause further delays but the right attorneys utilizing the parents of the ill children can be very convincing in both expediting a hearing claiming a potential public health crisis adding not just the Ag Commissioner but the Governor, Lt. Governor and anyone else in power that doesn’t want the negative publicity on their desk or at their feet. Perhaps the proper Parrish’s Representatives with elections coming.
Minds are like parachutes: they only function when they're open
Recent GBLX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:15:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:31:48 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2023 08:18:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 08:12:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/30/2023 12:00:24 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM